Cargando…
Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation
Alzheimer’s disease (AD), an age-related neurodegenerative disease, the most common causes of dementia is a multifactorial pathology categorized by a complex etiology. Numerous nutraceuticals have been clinically evaluated, but some of the trials failed. However, natural compounds have some limitati...
Autores principales: | Kanubaddi, Kiran Reddy, Yang, Shin-Han, Wu, Li-Wei, Lee, Chia-Hung, Weng, Ching-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294069/ https://www.ncbi.nlm.nih.gov/pubmed/30587972 http://dx.doi.org/10.2147/IJN.S179484 |
Ejemplares similares
-
Effective screen for amyloid β aggregation inhibitor
using amyloid β-conjugated gold nanoparticles
por: Han, Sun-Ho, et al.
Publicado: (2011) -
Peptide conformational imprints enhanced the catalytic activity of papain for esterification
por: Kanubaddi, Kiran Reddy, et al.
Publicado: (2022) -
Mechanisms of plastein formation, and prospective food and nutraceutical applications of the peptide aggregates()
por: Gong, Min, et al.
Publicado: (2014) -
Medical Plants and Nutraceuticals for Amyloid-β Fibrillation Inhibition
por: Witter, Steffi, et al.
Publicado: (2018) -
The Effect of Nanoparticles on Amyloid Aggregation Depends on the Protein Stability and Intrinsic Aggregation Rate
por: Cabaleiro-Lago, C., et al.
Publicado: (2011)